Navigation Links
China Cord Blood Corporation Announces Results of 2011 Annual General Meeting
Date:12/19/2011

HONG KONG, Dec. 19, 2011 /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), the first and largest umbilical cord blood banking operator in China, today announced the results of its 2011 Annual General Meeting, which was held on December 19, 2011, in Hong Kong.

At the Annual General Meeting, shareholders

  • Elected Ms. Ting Zheng and Dr. Yungang (Ken) Lu to serve on the Board of Directors until the 2014 Annual General Meeting of the Company or until their respective successors are duly appointed and qualified; and
  • Ratified the appointment of KPMG as the independent auditor of the Company for the financial year ending March 31, 2012, and authorized the directors to fix the remuneration of the auditors.

About China Cord Blood Corporation

China Cord Blood Corporation is the first and largest umbilical cord blood banking operator in China in terms of geographical coverage and is the only cord blood banking operator with multiple licenses.  Under current PRC government regulations, only one licensed cord blood banking operator is permitted to operate in each licensed region and only seven licenses have been authorized as of today.  China Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services.  For more information, please visit our website at http://www.chinacordbloodcorp.com

For more information, please contact:

China Cord Blood Corporation
Ms. Joeling Law
Tel: (+852) 3605-8180
Email: ir@chinacordbloodcorp.com

ICR, Inc.
In New York: Ashley M. Ammon: 1-646-277-1227
In Beijing: Wen Lei Zheng: +86-10-6583-7510
'/>"/>

SOURCE China Cord Blood Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. China Sky One Medical to Jointly Launch Adult Stem Cell Research Enterprise
2. China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2012 Financial Results
3. China Biologic to Host Earnings Conference Call on November 8, 2011 at 8:00 a.m. EST (NY)
4. Life Technologies Launches 3500 Dx Series Genetic Analyzers for In Vitro Diagnostic Use in China
5. China Biologic Named to Asias "200 Best Under a Billion" by Forbes Asia
6. United States Holds Global Lead in Breast Cancer Research Publications as China Surges to Forefront, According to Report
7. China Botanic Appoints Zack Zibing Pan as an Independent Director and Chairman of its Audit Committee
8. China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 19, 2011
9. Industrial Biotechnology China News 1109 - Annual Subscription
10. ThermoGenesis Announces Acceptance of AXP® Submission by Regulatory Body in China
11. China Cord Blood Corporation Files Its Annual Report on Form 20-F
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 30, 2014 CORD:USE Cord Blood Bank – ... it has entered into an Equity and Exclusive Services ... licensed a series of patented technologies for the isolation of ... applications.  Tianhe is performing Phase I/II clinical trials in ... using Tianhe,s Stem Cell Educator Therapy showing ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 ... solutions for drug discovery and related life ... consortium has chosen Genedata Selector as its ... (NGS) data. FUNGITECT is a European consortium ... fungal diseases via individualized anti-fungal drug therapies. ...
(Date:9/30/2014)... , Sept. 30, 2014  KemPharm, Inc., ... discovery and development of proprietary new molecular entity ... Patent and Trademark Office (USPTO) issued U.S. Patent ... entitled, "Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl ... Making and Use Thereof." The patent, ...
(Date:9/30/2014)... , Sept. 30, 2014 FemCap Inc., ... health announces its receipt of a patent No: US, ... cup has also received FDA clearance in the U.S., ... the CE in Europe. This patent is related to its ... this issuance, the company is releasing FemmyCycle Teen, a ...
Breaking Biology Technology:CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases 2CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases 3CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases 4FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 2FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 3KemPharm, Inc. Receives Patent from the USPTO for Novel Prodrug of Hydromorphone, KP511 2The FemmyCycle 2
... Beckman Coulter,Inc. (NYSE: BEC ), a ... automate, and innovate complex biomedical testing,announced today that ... present at the 19th Annual Piper Jaffray Healthcare,Conference ... (ET). (Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO ) The ...
... Highlighted by the,introduction of the IQQA(R) Enterprise ... radiology imaging market with its universal enterprise,solution, ... of 2D/3D/4D advanced,clinical applications on existing PACS ... code-level integration. Available on the,IQQA(R) Enterprise Engine ...
... Saint Louis University,(SLU) recognized St. Louis-based Sigma-Aldrich(TM) (Nasdaq: ... life science and high technology company,s,recent $1 million ... largest,in Sigma-Aldrich history, comes in the form of ... by the university,s medical school research,teams. (Photo: ...
Cached Biology Technology:Beckman Coulter to Present at the 19th Annual Piper Jaffray Healthcare Conference 2EDDA Technology Introduces Universal Enterprise Solution - Enabling 2D/3D/4D Advanced Clinical Applications on Existing PACS Workstations 2EDDA Technology Introduces Universal Enterprise Solution - Enabling 2D/3D/4D Advanced Clinical Applications on Existing PACS Workstations 3Saint Louis University Honors Sigma-Aldrich Corp. for $1 Million Donation 2
(Date:9/30/2014)... Here,s some hope: A new research report published in ... , explains how scientists developed a synthetic version ... embryo development in human and mouse eggs similar to ... cell during fertilization. , "We believe that the results ... our understanding of human fertilization by providing a precise ...
(Date:9/30/2014)... 30, 2014  Spectra Automation, a trusted ... biotech and power generation industries, announced today ... Manager, an easy-to-use and cost-effective data collection, ... development laboratories. Most upstream ... analyzer systems. Accessing and consolidating data from ...
(Date:9/30/2014)... 30, 2014) People who suffer from asthma may ... control their asthma besides properly taking medications and avoiding ... in the Annals of Allergy, Asthma and Immunology ... Allergy, Asthma and Immunology (ACAAI), asthma sufferers can learn ... The woman described in the Annals article improved her ...
Breaking Biology News(10 mins):Synthetic sperm protein raises the chance for successful in vitro fertilization 2Spectra Automation Introduces RECONN Bioprocess Manager 2Asthma symptoms kicking up? Check your exposure to air pollution 2
... A new study, supported in part by the National Heart, ... Health, suggests that a combination of mobile technology and remote ... behavior in adults. The study focused on the best way ... appear Monday, May 28, in the Archives of Internal ...
... A study led by researchers from McGill University provides ... heart a finding that promises to contribute to the ... heart tissue. The research, published in the Proceedings ... the muscle fibers in the heart wall are locally arranged ...
... getting stronger or weaker? Right now, it,s hard to know. ... this medical challenge by developing and applying a technique that ... technique was more sensitive in detecting bone loss than the ... it may find use in clinical settings, and could pave ...
Cached Biology News:NIH-funded study examines use of mobile technology to improve diet and physical activity behavior 2Study provides new insights into structure of heart muscle fibers 2Earlier detection of bone loss may be in future 2Earlier detection of bone loss may be in future 3Earlier detection of bone loss may be in future 4
... units/µL ,• High specific activity and processivity ... 'A' overhang ,• Processes ,A ... activity in primer extension and other molecular ... the enzyme, each lot has been functionally ...
... Recombinant DNA polymerase from Thermus aquaticus ... DNA contamination; 1 tube of 250 units ... LD (Low DNA), is the same enzyme ... purified through a proprietary separation process to ...
Our original highly-purified, robust Taq Polymerase which delivers consistently high yields and minimal background...
Taq DNA polymerase, 10,000U...
Biology Products: